Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Barr Barred From Premarin Equine-Based Generics; ANDA Status Under Review

Executive Summary

Barr Labs will meet with FDA to discuss the status of its conjugated estrogens ANDA following a district court decision barring the company from using Natural Biologics' raw material for an "AB"-rated generic

You may also be interested in...



Barr Still Betting On Generic Premarin; May Seek Other Estrogen Suppliers

Barr may pursue other raw material suppliers for generic versions of Wyeth's conjugated estrogens product Premarin if a recent court ruling against Barr's supplier Natural Biologics is not overturned on appeal

Barr Still Betting On Generic Premarin; May Seek Other Estrogen Suppliers

Barr may pursue other raw material suppliers for generic versions of Wyeth's conjugated estrogens product Premarin if a recent court ruling against Barr's supplier Natural Biologics is not overturned on appeal

Premarin Generics Reined In; Barr Supplier “Cannot Be Trusted,” Judge Says

Natural Biologics lacks the expertise to reproduce Wyeth's estrogen extraction process for conjugated estrogens (Premarin) by legitimate means, St. Paul, Minn. federal court Judge Joan Ericksen maintained in issuing a permanent injunction against the company

Related Content

UsernamePublicRestriction

Register

LL1135424

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel